Here are what the editors at HealthDay consider to be the most important developments in Internal Medicine for May 2020. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Globally, Women Less Likely to Develop Heart Disease Than Men
FRIDAY, May 29, 2020 (HealthDay News) — Women are less likely to have or die from cardiovascular disease than men, according to a study published online May 20 in The Lancet.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Metformin Recalled Due to Potential Cancer-Causing Chemical
FRIDAY, May 29, 2020 (HealthDay News) — A recall of the widely used diabetes drug metformin was announced by drug maker Apotex due to possible high levels of N-Nitrosodimethylamine (NDMA), which is believed to cause cancer in people.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 25 to 29, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
VA Slashes Use of Hydroxychloroquine to Treat COVID-19 Patients
FRIDAY, May 29, 2020 (HealthDay News) — The VA health system has stopped nearly all use of hydroxychloroquine to treat COVID-19 patients, Veterans Affairs Secretary Robert Wilkie said at a House hearing on Thursday.
Deferment of Elective Surgeries Due to COVID-19 Will Have Lasting Impact
FRIDAY, May 29, 2020 (HealthDay News) — At two years after the end of the elective orthopedic surgery deferment related to the COVID-19 pandemic, there will be a cumulative backlog of more than 1 million surgical cases in an optimistic scenario, according to a study published online May 12 in The Journal of Bone and Joint Surgery.
Abstract/Full Text (subscription or payment may be required)
Positive RT-PCR Findings Seen After COVID-19 Discharge
FRIDAY, May 29, 2020 (HealthDay News) — Some patients with COVID-19 have positive reverse transcriptase polymerase chain reaction (RT-PCR) results after discharge, according to a research letter published online May 28 in JAMA Network Open.
1990 to 2017 Saw Increase in Prevalence, Incidence of Psoriasis
FRIDAY, May 29, 2020 (HealthDay News) — From 1990 to 2017, there were increases in the global prevalence, incidence, and burden of suffering related to psoriasis, according to a report published in the May issue of the International Journal of Dermatology.
Abstract/Full Text (subscription or payment may be required)
Burden of Severe COVID-19 High in California, Washington State
FRIDAY, May 29, 2020 (HealthDay News) — For residents of California and Washington with COVID-19, the length of hospital stay and intensive care unit (ICU) admission are high, according to a study published online May 22 in The BMJ.
Multiple Sclerosis Tied to Higher Risk for CVD, Cerebrovascular Disease
THURSDAY, May 28, 2020 (HealthDay News) — Multiple sclerosis (MS) is associated with an increased risk for cardiovascular and cerebrovascular disease that is not completely accounted for by traditional vascular risk factors, according to a study published online May 4 in JAMA Neurology.
Abstract/Full Text (subscription or payment may be required)
CDC: Coronavirus Antibody Tests Still Not Accurate Enough
THURSDAY, May 28, 2020 (HealthDay News) — Coronavirus antibody test results may not be accurate enough to help guide decisions about whether to allow large groups of people to gather at work, schools, dormitories, correctional facilities, and other locations, the U.S. Centers for Disease Control and Prevention said Wednesday.
CBS News Article
More Information: CDC
Tooth Loss More Prevalent in Adults With Chronic Disease
THURSDAY, May 28, 2020 (HealthDay News) — Adults with severe chronic disease or with fair or poor general health have a higher prevalence of edentulism and severe tooth loss, according to research published in the May 29 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Parents Facing Higher Levels of Stress During Pandemic
THURSDAY, May 28, 2020 (HealthDay News) — Individuals, particularly parents, are coping with extreme stress related to the COVID-19 pandemic, according to the results of a survey released May 21 by the American Psychological Association (APA).
Disease-Modifying Drug Regimen May Offer Benefit in Heart Failure
THURSDAY, May 28, 2020 (HealthDay News) — The treatment effects of early comprehensive disease-modifying pharmacological therapy are considerable for patients with heart failure with reduced ejection fraction (HFrEF), according to a study published online May 21 in The Lancet.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
CV Toxicity Tied to Azithromycin and/or Hydroxychloroquine
THURSDAY, May 28, 2020 (HealthDay News) — Hydroxychloroquine and azithromycin may have a serious adverse impact on the cardiovascular system, according to a research letter published online May 22 in Circulation.
Abstract/Full Text (subscription or payment may be required)
Links Found Between Leaders of Medical Associations, Industry
THURSDAY, May 28, 2020 (HealthDay News) — There are extensive financial relationships between leaders of U.S. professional medical associations and industry, according to a study published online May 27 in The BMJ.
9.5 Percent Uninsured in U.S. From January Through June 2019
WEDNESDAY, May 27, 2020 (HealthDay News) — A total of 9.5 percent of persons were uninsured from January through June 2019, according to a report published online May 28 by the National Center for Health Statistics.
Improving Glycemic Control May Also Aid COVID-19 Outcomes
THURSDAY, May 28, 2020 (HealthDay News) — Insulin infusion helps achieve glycemic targets and may reduce the risk for poor outcomes in patients with hyperglycemia and COVID-19, according to a study published online May 19 in Diabetes Care.
Abstract/Full Text (subscription or payment may be required)
Spirituality May Have Protective Effect on QOL for Stroke Survivors
THURSDAY, May 28, 2020 (HealthDay News) — High spirituality among stroke survivors may moderate the association between care partner depressive symptomatology and quality of life (QOL) for survivors and their care partners, according to a study published online May 26 in Circulation: Cardiovascular Quality and Outcomes.
Abstract/Full Text (subscription or payment may be required)
Parents Struggling to Provide for Families During Pandemic
WEDNESDAY, May 27, 2020 (HealthDay News) — The COVID-19 pandemic poses risks to children’s health, well-being, and development as parents struggle to provide for their families, according to a survey released by the Urban Institute.
Palliative Care Linked to Fewer Readmissions for Heart Failure
WEDNESDAY, May 27, 2020 (HealthDay News) — For patients admitted with heart failure, palliative care is associated with fewer readmissions and less mechanical ventilation, according to a study published online May 27 in the Journal of the American Heart Association.
Abstract/Full Text (subscription or payment may be required)
African-Americans More Likely to Be Hospitalized With COVID-19
WEDNESDAY, May 27, 2020 (HealthDay News) — African-American patients have an increased likelihood of hospitalization for COVID-19, according to a report published online May 21 in Health Affairs.
Neuroimaging Features of COVID-19 Are Variable
WEDNESDAY, May 27, 2020 (HealthDay News) — Neuroimaging features of COVID-19 are variable among patients with acute neurological symptoms but are dominated by acute ischemic infarcts, according to a research letter published online May 21 in Radiology.
U.K. Patients Hospitalized With COVID-19 Are More Often Male
WEDNESDAY, May 27, 2020 (HealthDay News) — Patients hospitalized with COVID-19 are more often male and frequently have comorbidities, according to a study published online May 22 in the The BMJ.
Only One in Four U.S. Hospitals With ICUs Have Tele-ICU Services
WEDNESDAY, May 27, 2020 (HealthDay News) — In 2018, half of U.S. hospitals had the capacity to conduct telehealth-based outpatient visits, while only one in four had tele-intensive care unit (tele-ICU) capabilities, according to a research letter published online April 30 in the Annals of Internal Medicine.
Abstract/Full Text (subscription or payment may be required)
Early Informed Lung Cancer Patients Have Greater Survival Rates
WEDNESDAY, May 27, 2020 (HealthDay News) — Lung cancer patients who are given the opportunity to be informed of their diagnosis have a longer median survival time, according to a study published in the May issue of Psycho-Oncology.
Abstract/Full Text (subscription or payments may be required)
Primary Care Providers Report More Workplace Burnout, Anxiety
TUESDAY, May 26, 2020 (HealthDay News) — Primary care providers report more workplace burnout and higher scores for anxiety than other health care professionals, according to a study published in the May issue of the Journal of the American Board of Family Medicine.
USPSTF: Little Evidence Interventions Prevent Illicit Drug Use in Youth
TUESDAY, May 26, 2020 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) concludes that current evidence is inadequate for assessing the balance of benefits and harms of primary care interventions for preventing illicit drug use among children, adolescents, and young adults. These findings form the basis of a final recommendation statement published in the May 26 issue of the Journal of the American Medical Association.
Evidence Report
Final Recommendation Statement
WHO Suspends Testing of Hydroxychloroquine in COVID-19 Patients
TUESDAY, May 26, 2020 (HealthDay News) — The World Health Organization has suspended use of the antimalarial drug hydroxychloroquine in a clinical trial of treatments of COVID-19 after a study revealed that patients taking the drug are at increased risk for death and serious heart problems.
New Medicare Benefit Would Limit Insulin Copays to $35 a Month
TUESDAY, May 26, 2020 (HealthDay News) — Reacting to skyrocketing prices for insulin, the Trump Administration announced on Tuesday a new benefit that would limit Medicare recipients’ copays for insulin to a maximum of $35 a month and save them about $446 a year if they have prescription plans that offer the benefit.
High Prevalence of Primary Aldosteronism Observed
TUESDAY, May 26, 2020 (HealthDay News) — Primary aldosteronism is prevalent and increases in parallel with hypertension severity, according to a study published online May 26 in the Annals of Internal Medicine.
Lasting Drop Seen in CRC Incidence, Death After Negative Colonoscopy
TUESDAY, May 26, 2020 (HealthDay News) — Colorectal cancer (CRC) incidence and mortality are reduced for a period of 17.4 years following a single negative screening colonoscopy, according to a study published online May 26 in the Annals of Internal Medicine.
Environmental Chemical Exposure Tied to Kidney Disease in the U.S.
TUESDAY, May 26, 2020 (HealthDay News) — Increased exposure to heavy metal lead, cadmium, or volatile organic compounds may be associated with an increased prevalence of chronic kidney disease (CKD), according to a study published online May 22 in the Clinical Journal of the American Society of Nephrology.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Right Ventricular Dilation Linked to Mortality in COVID-19
TUESDAY, May 26, 2020 (HealthDay News) — Right ventricular dilation is associated with in-hospital mortality among patients hospitalized with COVID-19, according to a study published online May 15 in JACC: Cardiovascular Imaging.
Abstract/Full Text (subscription or payment may be required)
Remdesivir Beats Placebo for Time to COVID-19 Recovery
TUESDAY, May 26, 2020 (HealthDay News) — For adults hospitalized with COVID-19 with lower respiratory tract infection, time to recovery is shorter with remdesivir than placebo, according to a study published online May 22 in the New England Journal of Medicine.
Hydroxychloroquine Plus Macrolides No Benefit in COVID-19
TUESDAY, May 26, 2020 (HealthDay News) — For patients with COVID-19 requiring hospitalization, there is no evidence of benefit for use of hydroxychloroquine or chloroquine with or without a macrolide, according to a study published online May 22 in The Lancet.
Adenovirus Type-5 Vectored COVID-19 Vaccine Shows Promise
TUESDAY, May 26, 2020 (HealthDay News) — A recombinant adenovirus type-5 (Ad5) vectored COVID-19 vaccine is safe, tolerable, and immunogenic, according to a study published online May 22 in The Lancet.
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of May 18 to 22, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
Read Full Article
U.S. Offers $1.2 Billion to Drug Company for COVID-19 Vaccine Research
FRIDAY, May 22, 2020 (HealthDay News) — The U.S. Department of Health and Human Services said Thursday it would provide up to $1.2 billion to AstraZeneca to develop a potential COVID-19 vaccine from a lab in Oxford, England.
CDC: COVID-19 Not Spread Easily From Contaminated Surfaces
2013 to 2024 Saw Decrease in Benzodiazepine Prescribing 
Pediatricians Report Immigrant Families Avoiding Care for Their Children 
Psychiatrists Only Agree 55 Percent of the Time on Diagnoses 
Napping Opportunity May Improve Clinical Performance of Anesthesia Residents 
Socioeconomic Status Linked to Mortality After Acute Hip Fracture Surgery 
People Using Illicitly Sourced Fentanyl Face Worse Outcomes Than Medically Sourced Users 
Data Reveal No Hypersensitivity Due to Axillary Brachial Plexus Block Alone 
Tranexamic Acid Yields Lower Incidence of Red-Cell Transfusion in Noncardiac Surgery 
.jpg)
